2. Academic Validation
  3. Small Peptides Able to Suppress Prostaglandin E₂ Generation in Renal Mesangial Cells

Small Peptides Able to Suppress Prostaglandin E₂ Generation in Renal Mesangial Cells

  • Molecules. 2018 Jan 13;23(1):158. doi: 10.3390/molecules23010158.
Sofia Vasilakaki 1,  Oleksandr Pastukhov 2,  Thomas Mavromoustakos 3,  Andrea Huwiler 4,  George Kokotos 5
Affiliations

Affiliations

  • 1 Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Athens 15771, Greece. [email protected].
  • 2 Institute of Pharmacology, University of Bern, Bern 3010, Switzerland. [email protected].
  • 3 Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Athens 15771, Greece. [email protected].
  • 4 Institute of Pharmacology, University of Bern, Bern 3010, Switzerland. [email protected].
  • 5 Laboratory of Organic Chemistry, Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Athens 15771, Greece. [email protected].
PMID: 29342835 DOI: 10.3390/molecules23010158
Abstract

Peptide drug discovery may play a key role in the identification of novel medicinal agents. Here, we present the development of novel small Peptides able to suppress the production of PGE₂ in mesangial cells. The new compounds were generated by structural alterations applied on GK115, a novel inhibitor of secreted Phospholipase A₂, which has been previously shown to reduce PGE₂ synthesis in rat renal mesangial cells. Among the synthesized compounds, the tripeptide derivative 11 exhibited a nice dose-dependent suppression of PGE₂ production, similar to that observed for GK115.

Keywords

inhibitors; mesangial cells; peptides; prostaglandin E2; secreted phospholipase A2.

Figures
Products